利用人类遗传学开发化学预防癌症-太好一个机会被错过了
Ulrike Peters1, Ian Tomlinson2
1Public Health Sciences Division, Fred Hutchinson Cancer Center and Department of Epidemiology, University of Washington, Seattle, Washington.
基因组研究确定了疾病风险因素,但生殖系遗传学在癌症预防药物开发中未得到充分利用. 利用这些数据为有针对性的癌症化学预防提供了重大机会.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大规模的遗传研究确定了人群中的许多疾病风险因素.
- 遗传信息为治疗心血管疾病和癌症 (基于体质突变) 等疾病的药物开发提供了信息.
- 有一个显着的不愿意利用生殖系遗传数据开发癌症预防药物.
研究的目的:
- 倡导开发基于人类生殖系遗传学的向癌症化学预防策略的迫切需要.
- 突出胚胎系遗传数据在减少癌症发病率方面的未充分利用的潜力.
- 强调与现有的非药物癌症风险降低措施的相似之处.
主要方法:
- 对遗传学研究和药物开发当前实践的审查.
- 分析基于体质突变的癌症药物开发与预防的生殖系遗传学之间的差距.
- 在癌症化学预防研究中转向生殖系遗传学的范式转变的论点.
主要成果:
- 生殖系遗传变异,包括常见的多态,显著调节癌症风险.
- 在人类生殖系遗传学中,存在许多用于预防癌症的潜在药物标.
- 目前在基因基因基因基因癌症预防方面的努力是不够的,尽管潜力很高.
结论:
- 迫切需要采取协调一致的努力,以利用生殖系遗传学开发有针对性的癌症预防药物.
- 新型化疗预防策略有显著的机会,这些策略由生殖系遗传数据提供信息.
- 很可能需要来自国家和国际机构的专门资金来推进这个领域.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Mutagenicity and Carcinogenicity
